Midgard Science

Labs / CDMO: development & manufacturing

Sinopep-Allsino Biopharmaceutical Co., Ltd.

Hangzhou, China · sinopep.com

GLP · GMP · FDA registered

Sinopep-Allsino Biopharmaceutical Co., Ltd. develops and manufactures peptides, oligonucleotides, small molecules, and related conjugates for research, development, clinical, and commercial programs. It serves qualified research and pharmaceutical organizations from China, with facilities in Jiangsu Lianyungang and other operations supporting global clients.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Custom Peptide Synthesis

    Synthesizes custom research-grade peptides for discovery research and project-specific sequences.

  • Custom Oligo Synthesis

    Produces custom oligonucleotides including ASO, siRNA, miRNA, PMO, aptamer, CpG, and decoy oligos.

  • Conjugate Synthesis

    Makes peptide, small-molecule, and oligo conjugates such as POCs and PPMOs.

  • FTE Services

    Provides a full-time-equivalent model with dedicated personnel assigned to client projects for a fixed period.

  • Peptide CDMO Services

    Provides end-to-end CMC development and cGMP manufacturing of peptide APIs from early development through commercialization.

  • Oligo CDMO Services

    Provides end-to-end oligonucleotide manufacturing from research-grade to clinical-grade material.

  • Formulation Services

    Develops finished dosage forms including oral solid dosage forms, lyophilized powder injections, and small-volume injections.

  • Generic APIs

    Develops and manufactures peptide, oligo, and small molecule active pharmaceutical ingredients.

What they work on

Modalities
Small molecule, Peptide, Oligonucleotide
Assays and studies
RP-HPLC, MS, IEX, IP-RP-HPLC, forced degradation, impurity profiling, stability studies, analytical method development, analytical method validation
Instruments and platforms
solid-phase peptide synthesis (SPPS) platforms, liquid-phase peptide synthesis (LPPS) platforms, Distributed Control System (DCS), real-time PAT, dynamic axial compression columns
Scale and capacity
peptide capacity of 20–30 metric tons annually, oligonucleotide manufacturing capacity of 1,000 kg annually, PMO capacity of 100 kg annually, peptide-oligo conjugate capacity of 200 kg annually, production up to hundreds of kilograms, SPPS reactors up to 3,000 L, LPPS reactors up to 10,000 L, dynamic axial compression columns up to 1,200 mm
What to send
Sequence in three- or one-letter format · Quantity selection for research peptide quote · Structure file upload optional
Type
CRDMO
Sites
Jiangsu Lianyungang, China
Quality
FDA/ICH guidelines (peptide CDMO services) · U.S. FDA inspections (passed four inspections since 2009) · FDA & EMA compliant (formulation facilities) · GMP (manufacturing facilities) · global regulatory requirements (manufacturing facilities in the United States, European Union, China, and Japan)
Serves
global, United States, European Union, China, Japan
Address
1378 Wenyi West Road, Yuhang District, Hangzhou City, Zhejiang 311121, China
Founded
2009

Public records

FDA establishment
3005460102
FDA drug establishment
Sinopep-Allsino Biopharmaceutical Co., Ltd. source
FDA drug establishment registration
3005460102 · ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK source

Similar labs. Porton, WuXi STA, VxP Biologics, ARSI Canada Inc

Found in a contract services directory. Listing built from sinopep.com. Work here? Claim this listing.

Sinopep-Allsino Biopharmaceutical Co., Ltd. · Midgard Science